G protein-coupled receptor 143
Última atualização 18 de ago de 2020
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
A GPR143 gene, also known as OA1, provides instructions for making a protein that is involved in the coloring (pigmentation) of the eyes and skin. This protein is made in the light-sensitive tissue at the back of the eye (the retina) and in skin cells. The GPR143 protein is part of a signaling pathway that controls the growth and maturation of melanosomes, which are cellular structures that produce and store a pigment called melanin. Melanin is the substance that gives skin, hair, and eyes their colour. In the retina, this pigment also plays a critical role in normal vision.
Escolhas de vídeos para GenesBiblioteca de vídeos
Normal function
A GPR143 gene, also known as OA1, provides instructions for making a protein that is involved in the coloring (pigmentation) of the eyes and skin. This protein is made in the light-sensitive tissue at the back of the eye (the retina) and in skin cells. The GPR143 protein is part of a signaling pathway that controls the growth and maturation of melanosomes, which are cellular structures that produce and store a pigment called melanin. Melanin is the substance that gives skin, hair, and eyes their colour. In the retina, this pigment also plays a critical role in normal vision.
Conditions referring to this gene or chromosome
Other names
GP143_HUMAN
OA1
ocular albinism 1 (Nettleship-Falls)
ocular albinism type 1 protein
Related patient information and medicines

Patient information leaflet
Câncer de mama
...:/health/breast-cancer-leaflet](https://patient.info/health/breast-cancer-leaflet) Follow Patient: Website: [/](https://patient.info/) Facebook: [https://www.facebook.com/patient](https://www.facebook.com/patient) Twitter: [https://twitter.com/patient](https://twitter.com/patient) Pinterest:.

Patient information leaflet
Câncer de garganta
(The throat is usually sprayed ... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer. The same instrument has a light source similar to a nasal.

Patient information leaflet
Doença renal diabética
Doença renal diabética (diabetic nephropathy) is a complication that occurs in some people with diabetes. Diabetic kidney disease is one of the causes of chronic kidney disease Chronic kidney disease , a long-term condition where the kidneys do not work as well as they should. In diabetic kidney disease, the filters of the kidneys, the glomeruli,.

Patient information leaflet
Síndrome nefrótica
Nephrotic syndrome is a condition where the 'filters' in the kidney become 'leaky' and large amounts of protein leak from the blood into the urine. The main symptom is fluid retention (oedema) which is mainly due to the low protein level in the blood. Various diseases can cause nephrotic syndrome, some more serious than others. A syndrome is a set.

Patient information leaflet
Posso tomar Chaga e Cordyceps juntos?
Tomar chaga and cordyceps together may increase the risk of bruising or bleeding. Caffeine Cordyceps may have mild stimulant properties and can interact com adenosine receptors. ...inesOur Verificador de Interações de Medicamentos helps you check whether your prescriptions, over-the-counter medicines, e suplementos are safe to take together. Disclaimer.

Patient information leaflet
Posso tomar Apixaban e Rybelsus juntos?
These two medicines work in different ways and do not... Why this happens Apixaban is an anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Rybelsus é a GLP-1 receptor agonist used for type 2 diabetes that mimics a natural hormone to lower sangue sugar. They are processed by different pathways in the liver and.
Leitura adicional e referências
- G protein-coupled receptor 143; MedlinePlus, National Library of Medicine.
- Camand O, Boutboul S, Arbogast L, Roche O, Sternberg C, Sutherland J, Levin A, Heon E, Menasche M, Dufier J, Abitbol M. Mutational analysis of the OA1 gene in ocular albinism. Ophthalmic Genet. 2003 Sep;24(3):167-73. doi: 10.1076/opge.24.3.167.15605.
- Cortese K, Giordano F, Surace EM, Venturi C, Ballabio A, Tacchetti C, Marigo V. The ocular albinism type 1 (OA1) gene controls melanosome maturation and size. Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4358-64. doi: 10.1167/iovs.05-0834.
- Innamorati G, Piccirillo R, Bagnato P, Palmisano I, Schiaffino MV. The melanosomal/lysosomal protein OA1 has properties of a G protein-coupled receptor. Pigment Cell Res. 2006 Apr;19(2):125-35. doi: 10.1111/j.1600-0749.2006.00292.x.
- Lewis RA. Ocular Albinism, X-Linked - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. 2004 Mar 12 [updated 2015 Nov 19]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1343/
- Mayeur H, Roche O, Vetu C, Jaliffa C, Marchant D, Dollfus H, Bonneau D, Munier FL, Schorderet DF, Levin AV, Heon E, Sutherland J, Lacombe D, Said E, Mezer E, Kaplan J, Dufier JL, Marsac C, Menasche M, Abitbol M. Eight previously unidentified mutations found in the OA1 ocular albinism gene. BMC Med Genet. 2006 Apr 28;7:41. doi: 10.1186/1471-2350-7-41.
- Oetting WS. New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene. Hum Mutat. 2002 Feb;19(2):85-92. doi: 10.1002/humu.10034.
- Schiaffino MV, Tacchetti C. The ocular albinism type 1 (OA1) protein and the evidence for an intracellular signal transduction system involved in melanosome biogenesis. Pigment Cell Res. 2005 Aug;18(4):227-33. doi: 10.1111/j.1600-0749.2005.00240.x.
- Shen B, Samaraweera P, Rosenberg B, Orlow SJ. Ocular albinism type 1: more than meets the eye. Pigment Cell Res. 2001 Aug;14(4):243-8. doi: 10.1034/j.1600-0749.2001.140403.x.
Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.
Inscreva-se no boletim informativo do Patient
Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.

